Cefixime trihydrate PurCert Secondary Reference Standard (CRM) [Includes characterization data]

PurCert


Synonym: 
Linear Formula:  C16H17N5O8S2
Molecular Weight:  507.5 g/mol
CAS Number: 125110-14-7

Properties

Assay Purity >= 98 %
M pt. 218-225
Form Powder

Safety Information

Hazard Statement(s) H317,H334
Precautionary Statement  P261 - P272 - P280 - P284 - P302 + P352 - P333 + P313
GHS Pictogram
Signal word Danger
HS Code 2941906000
Storage Temp. 2-8°C
Storage Class 11 - Combustible Solids

Description

Application
It is administered orally in tablets capsules or suspensions to treat infections including uncomplicated gonorrhea pharyngitis tonsillitis acute exacerbations of chronic bronchitis urinary tract infections and otitis media caused by susceptible Gram-negative and Gram-positive bacteria.

Purpose
Cefixime trihydrate inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins effective against pathogens like Streptococcus pneumoniae Haemophilus influenzae Moraxella catarrhalis and Neisseria gonorrhoeae with enhanced -lact

General Description
Cefixime trihydrate is the trihydrate form of the third-generation cephalosporin antibiotic cefixime with molecular formula CHNOS (MW 507.50 gmol CAS 125110-14-7) featuring a -lactam ring fused to a dihydrothiazine ring with a (2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl side chain at C-7 and a vinyl group at C-3 appearing as a white to off-white crystalline powder.